Published in Ann Allergy Asthma Immunol on January 17, 2011
Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: a comparative study in Mexican, West African, and European populations. Am J Clin Nutr (2006) 1.98
Efficacy and safety of rupatadine for allergic rhino-conjunctivitis: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis. Curr Med Res Opin (2013) 1.92
Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest (2007) 1.84
A review of the evidence from comparative studies of levocetirizine and desloratadine for the symptoms of allergic rhinitis. Clin Ther (2005) 1.45
Diagnosing nonimmediate reactions to cephalosporins. J Allergy Clin Immunol (2012) 1.41
Why do doctors and patients not follow guidelines? Curr Opin Allergy Clin Immunol (2009) 1.35
Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language. J Allergy Clin Immunol (2013) 1.33
Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol (2006) 1.26
Quality of life in Duchenne muscular dystrophy: the subjective impact on children and parents. J Child Neurol (2011) 1.13
Possible role of climate changes in variations in pollen seasons and allergic sensitizations during 27 years. Ann Allergy Asthma Immunol (2010) 1.13
The link between allergic rhinitis and asthma: the united airways disease. Expert Rev Clin Immunol (2010) 1.11
Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol (2007) 1.11
The ImmunoCAP ISAC molecular allergology approach in adult multi-sensitized Italian patients with respiratory symptoms. Clin Biochem (2011) 1.08
Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study. J Allergy Clin Immunol (2010) 1.06
Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity. J Allergy Clin Immunol (2002) 1.05
Bridging allergologic and botanical knowledge in seasonal allergy: a role for phenology. Ann Allergy Asthma Immunol (2010) 1.04
Methionine synthase (MTR) 2756 (A --> G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome. Am J Med Genet A (2003) 1.01
Perturbations of natural killer cell regulatory functions in respiratory allergic diseases. J Allergy Clin Immunol (2007) 0.98
Clara cell 16 protein in COPD sputum: a marker of small airways damage? Respir Med (2007) 0.97
Provocation tests in diagnosing drug hypersensitivity. Curr Pharm Des (2008) 0.97
Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin Transl Allergy (2012) 0.97
Hypersensitivity to lamotrigine and nonaromatic anticonvulsant drugs: a review. Curr Pharm Des (2008) 0.96
Genetic determinants of folate and vitamin B12 metabolism: a common pathway in neural tube defect and Down syndrome? Clin Chem Lab Med (2003) 0.95
How adherent to sublingual immunotherapy prescriptions are patients? The manufacturers' viewpoint. J Allergy Clin Immunol (2010) 0.94
Specific immunotherapy for respiratory allergy: state of the art according to current meta-analyses. Ann Allergy Asthma Immunol (2009) 0.93
Allergic diseases and their impact on quality of life. Ann Allergy Asthma Immunol (2006) 0.92
Quantitative assessment of the adherence to sublingual immunotherapy. J Allergy Clin Immunol (2004) 0.90
Development and testing of the quality of life in children with vernal keratoconjunctivitis questionnaire. Am J Ophthalmol (2007) 0.89
Allergen-specific immunotherapy in asthmatic children: from the basis to clinical applications. Expert Rev Vaccines (2013) 0.89
Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha. Eur J Immunol (2002) 0.89
Asthma management failure: a flaw in physicians' behavior or in patients' knowledge? J Asthma (2011) 0.88
Environmental influence on the worldwide prevalence of a 776C->G variant in the transcobalamin gene (TCN2). J Med Genet (2007) 0.87
New insights into airway remodelling in asthma and its possible modulation. Curr Opin Allergy Clin Immunol (2008) 0.87
AQUA: Allergy Questionnaire for Athletes. Development and validation. Med Sci Sports Exerc (2009) 0.86
Disability in COPD and its relationship to clinical and patient-reported outcomes. Curr Med Res Opin (2011) 0.86
Asthma mortality, inhaled steroids, and changing asthma therapy in Argentina (1990-1999). Respir Med (2005) 0.86
Economic evaluation of sublingual immunotherapy vs symptomatic treatment in adults with pollen-induced respiratory allergy: the Sublingual Immunotherapy Pollen Allergy Italy (SPAI) study. Ann Allergy Asthma Immunol (2006) 0.86
Oxidative stress and respiratory system: pharmacological and clinical reappraisal of N-acetylcysteine. COPD (2014) 0.86
Patient knowledge, perceptions, expectations and satisfaction on allergen-specific immunotherapy: a survey. Respir Med (2012) 0.86
Sublingual Immunotherapy: Clinical Indications in the WAO-SLIT Position Paper. World Allergy Organ J (2010) 0.85
Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease. Neuroreport (2004) 0.84
An update on allergen immunotherapy and asthma. Curr Opin Pulm Med (2014) 0.84
Harmful effect of immunotherapy in children with combined snail and mite allergy. J Allergy Clin Immunol (2002) 0.84
Celecoxib tolerability in patients with hypersensitivity (mainly cutaneous reactions) to nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol (2005) 0.84
Hypersensitivity reactions to non beta-lactam antimicrobial agents, a statement of the WAO special committee on drug allergy. World Allergy Organ J (2013) 0.84
A review of the use of fluticasone furoate since its launch. Expert Opin Pharmacother (2011) 0.84
The clinical characteristics of respiratory allergy in immigrants in northern Italy. Int Arch Allergy Immunol (2008) 0.84
Office spirometry can improve the diagnosis of obstructive airway disease in primary care setting. Respir Med (2009) 0.84
Pharmacokinetics of Der p 2 allergen and derived monomeric allergoid in allergic volunteers. Int Arch Allergy Immunol (2005) 0.84
Clinical and cytologic characteristics of allergic rhinitis in elderly patients. Ann Allergy Asthma Immunol (2012) 0.84
Homocysteine is a determinant of ApoA-I and both are associated with ankle brachial index, in an ambulatory elderly population. Atherosclerosis (2010) 0.83
Sublingual immunotherapy for allergic rhinitis and conjunctivitis. Immunotherapy (2013) 0.83
The possible influence of the environment on respiratory allergy: a survey on immigrants to Italy. Ann Allergy Asthma Immunol (2011) 0.83
Skin tests in the diagnosis of drug hypersensitivity reactions. Curr Pharm Des (2008) 0.83
Treatment of acquired cold urticaria with cetirizine and zafirlukast in combination. J Am Acad Dermatol (2003) 0.83
Hypersensitivity reactions to iodinated contrast media. Curr Pharm Des (2006) 0.83
Patients with asthma and comorbid allergic rhinitis: is optimal quality of life achievable in real life? PLoS One (2012) 0.83
Clinical, functional, and immunologic effects of sublingual immunotherapy in birch pollinosis: a 3-year randomized controlled study. J Allergy Clin Immunol (2005) 0.83
When allergic rhinitis is not only allergic. Am J Rhinol Allergy (2009) 0.82
The relationship between asthma control and quality-of-life impairment due to chronic cough: a real-life study. Ann Allergy Asthma Immunol (2008) 0.82
Serum cytotoxic T lymphocyte-associated antigen 4 in Hymenoptera venom allergy and its modulation by specific immunotherapy. J Allergy Clin Immunol (2008) 0.82
Allele epsilon 4 of APOE is a stronger predictor of Alzheimer risk in Sicily than in continental South Italy. Neurosci Lett (2005) 0.82
Prevalence of dementia in mountainous village of Sicily. J Neurol Sci (2009) 0.82
Biomarker discovery in asthma and COPD by proteomic approaches. Proteomics Clin Appl (2014) 0.82
Chronic obstructive pulmonary disease patient well-being and its relationship with clinical and patient-reported outcomes: a real-life observational study. Respiration (2011) 0.82
Allergy training and immunotherapy in Latin America: results of a regional overview. Ann Allergy Asthma Immunol (2013) 0.82
The effect of intranasal corticosteroids on asthma control and quality of life in allergic rhinitis with mild asthma. J Asthma (2010) 0.82
Airway remodelling in children: when does it start? Curr Opin Allergy Clin Immunol (2007) 0.81
Molecular allergy diagnosis: we need to become more knowledgeable. Ann Allergy Asthma Immunol (2012) 0.81
Component-resolved diagnosis in pediatric allergic rhinoconjunctivitis and asthma. Curr Opin Allergy Clin Immunol (2013) 0.81
The safety of allergen specific sublingual immunotherapy. Curr Drug Saf (2007) 0.81
A world allergy organization international survey on diagnostic procedures and therapies in drug allergy/hypersensitivity. World Allergy Organ J (2011) 0.81
Gene-gene interactions of IL13 and IL4RA variants in immediate allergic reactions to betalactam antibiotics. Pharmacogenet Genomics (2006) 0.81
IgE-mediated hypersensitivity to cephalosporins. Curr Pharm Des (2006) 0.81
Impact of bariatric surgery on pulmonary function and nitric oxide in asthmatic and non-asthmatic obese patients. J Asthma (2011) 0.81
Association of vitamin B12, folate and homocysteine with functional and pathological characteristics of the elderly in a mountainous village in Sicily. Clin Chem Lab Med (2007) 0.81
Cross-sectional comparison of the characteristics of respiratory allergy in immigrants and Italian children. Pediatr Allergy Immunol (2014) 0.80
Focus on cat allergen (Fel d 1): immunological and aerodynamic characteristics, modality of airway sensitization and avoidance strategies. Int Arch Allergy Immunol (2003) 0.80
Effects of fexofenadine and other antihistamines on components of the allergic response: adhesion molecules. J Allergy Clin Immunol (2003) 0.80
Obstructive lung diseases and inhaler treatment: results from a national public pragmatic survey. Respir Res (2013) 0.80
Imipenem in patients with immediate hypersensitivity to penicillins. N Engl J Med (2006) 0.80
Oral and sublingual immunotherapy in paediatric patients. Curr Opin Allergy Clin Immunol (2003) 0.80
Synthesis, characterization and immunochemical evaluation of cephalosporin antigenic determinants. J Mol Recognit (2003) 0.80
Eosinophilic esophagitis: which role for food and inhalant allergens? Asia Pac Allergy (2012) 0.80
Frequency of acute systemic reactions in patients with allergic rhinitis and asthma treated with sublingual immunotherapy. Ann Allergy Asthma Immunol (2008) 0.80
Emerging drugs for allergic conjunctivitis. Expert Opin Emerg Drugs (2014) 0.80
Safety and tolerability of sublingual immunotherapy in clinical trials and real life. Curr Opin Allergy Clin Immunol (2013) 0.80
Ranking in importance of allergen extract characteristics for sublingual immunotherapy by Italian specialists. Allergy Asthma Proc (2014) 0.80
Helicobacter pylori serologic status has no influence on the association between fucosyltransferase 2 polymorphism (FUT2 461 G->A) and vitamin B-12 in Europe and West Africa. Am J Clin Nutr (2012) 0.80
Administration of a polyvalent mechanical bacterial lysate to elderly patients with COPD: Effects on circulating T, B and NK cells. Immunol Lett (2012) 0.79
Exome-Wide Association Study Identifies New Low-Frequency and Rare UGT1A1 Coding Variants and UGT1A6 Coding Variants Influencing Serum Bilirubin in Elderly Subjects: A Strobe Compliant Article. Medicine (Baltimore) (2015) 0.79
Emerging sublingual immunotherapy drugs. Expert Opin Pharmacother (2010) 0.79
Non-injection routes for allergen immunotherapy: focus on sublingual immunotherapy. Inflamm Allergy Drug Targets (2006) 0.79
Sublingual immunotherapy: update 2006. Curr Opin Allergy Clin Immunol (2006) 0.79